Day One Biopharmaceuticals, Inc. Common Stock
Symbol: DAWN (NASDAQ)
7.18
▼ (-3.17%) -0.235
Company Description:
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
Key Stats
- Today's Open: $7.4
- Today's High: $7.435
- Today's Low: $7.175
- Today's Volume: 871.69K
- Yesterday Close: $7.41
- Yesterday High: $7.48
- Yesterday Low: $7.265
- Yesterday Volume: 567.54K
- Last Min Volume: 5
- Last Min High: $7.175
- Last Min Low: $7.175
- Last Min VWAP: $7.175
Company Profile
- Name: Day One Biopharmaceuticals, Inc. Common Stock
- Website: https://www.dayonebio.com
- Listed Date: 2021-05-27
- Location: BRISBANE, CA
- Market Status: Active
- CIK Number: 0001845337
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $765.17M
- Round Lot: 100
- Outstanding Shares: 102.43M
- Asset Type: CS
RECENT FILINGS FOR DAWN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-18 | 144 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-06 | SCHEDULE 13G/A | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-07-17 | SCHEDULE 13G | View |
| 2025-07-14 | 4 | View |
| 2025-06-18 | 4 | View |
| 2025-06-18 | 3 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |